Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Regenxbio
RGNX
$638M
| $7.24M | ﹤0.01% |
343,615
+16,164
| +5% | +$288K |
|
2152
Community Health Systems
CYH
$412M
| $7.19M | ﹤0.01% |
2,054,186
-3,528,846
| -63% | -$11.9M |
|
2153
Zentalis Pharmaceuticals
ZNTL
$331M
| $7.19M | ﹤0.01% |
455,937
+10,114
| +2% | +$139K |
|
2154
Origin Bancorp
OBK
$1.69B
| $7.17M | ﹤0.01% |
229,624
+3,320
| +1% | +$103K |
|
2155
Chegg
CHGG
$114M
| $7.17M | ﹤0.01% |
946,581
+48,723
| +5% | +$446K |
|
2156
Vicor
VICR
$9.85B
| $7.17M | ﹤0.01% |
187,384
+5,702
| +3% | +$222K |
|
2157
Scholar Rock
SRRK
$5.49B
| $7.15M | ﹤0.01% |
402,481
+8,343
| +2% | +$131K |
|
2158
TechTarget
TTGT
$323M
| $7.15M | ﹤0.01% |
216,019
+6,936
| +3% | +$228K |
|
2159
Century Aluminum
CENX
$4.47B
| $7.13M | ﹤0.01% |
463,524
-386,655
| -45% | -$4.34M |
|
2160
Artivion
AORT
$1.33B
| $7.11M | ﹤0.01% |
336,143
+10,058
| +3% | +$187K |
|
|
XRN
2161
Chiron Real Estate Inc
XRN
$467M
| $7.1M | ﹤0.01% |
162,272
+3,633
| +2% | +$174K |
|
2162
Movado Group
MOV
$866M
| $7.06M | ﹤0.01% |
252,600
+14,694
| +6% | +$412K |
|
2163
Fate Therapeutics
FATE
$291M
| $7.02M | ﹤0.01% |
956,331
-26,688
| -3% | -$165K |
|
2164
Energy Recovery
ERII
$459M
| $7.02M | ﹤0.01% |
444,479
+5,274
| +1% | +$83.9K |
|
2165
Kanzhun
BZ
$7.36B
| $7.02M | ﹤0.01% |
400,244
| – | – |
|
2166
Universal Insurance Holdings
UVE
$1.23B
| $7M | ﹤0.01% |
344,284
-33,568
| -9% | -$604K |
|
|
PRSU
2167
Pursuit Attractions and Hospitality Inc
PRSU
$1.41B
| $6.99M | ﹤0.01% |
176,967
+5,635
| +3% | +$196K |
|
|
DHIL
2168
DELISTED
Diamond Hill
DHIL
| $6.99M | ﹤0.01% |
45,316
+2,984
| +7% | +$465K |
|
|
TUP
2169
DELISTED
Tupperware Brands Corporation
TUP
| $6.99M | ﹤0.01% |
5,212,722
+662,185
| +15% | +$1.06M |
|
2170
Opko Health
OPK
$978M
| $6.97M | ﹤0.01% |
5,809,298
+75,598
| +1% | +$75.7K |
|
2171
Ameresco
AMRC
$1.2B
| $6.96M | ﹤0.01% |
288,514
+36,431
| +14% | +$816K |
|
|
CYBR
2172
DELISTED
CyberArk
CYBR
| $6.94M | ﹤0.01% |
26,130
+1,187
| +5% | +$294K |
|
|
CTEV
2173
Claritev Corp
CTEV
$414M
| $6.88M | ﹤0.01% |
212,010
-1,052
| -0.5% | -$44.3K |
|
2174
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.9B
| $6.86M | ﹤0.01% |
72,066
-21,450
| -23% | -$2.03M |
|
2175
AvePoint
AVPT
$2.83B
| $6.83M | ﹤0.01% |
862,978
+7,775
| +0.9% | +$61.2K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.